Swarna A. Gamage

2.3k total citations
39 papers, 1.7k citations indexed

About

Swarna A. Gamage is a scholar working on Molecular Biology, Organic Chemistry and Toxicology. According to data from OpenAlex, Swarna A. Gamage has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 17 papers in Organic Chemistry and 7 papers in Toxicology. Recurrent topics in Swarna A. Gamage's work include Cancer therapeutics and mechanisms (15 papers), Synthesis and Biological Evaluation (11 papers) and Bioactive Compounds and Antitumor Agents (7 papers). Swarna A. Gamage is often cited by papers focused on Cancer therapeutics and mechanisms (15 papers), Synthesis and Biological Evaluation (11 papers) and Bioactive Compounds and Antitumor Agents (7 papers). Swarna A. Gamage collaborates with scholars based in New Zealand, United States and United Kingdom. Swarna A. Gamage's co-authors include William A. Denny, Julie A. Spicer, Bruce C. Baguley, Graeme J. Finlay, Vijayalekshmi Sarojini, Gordon W. Rewcastle, Michael P. Hay, Robert F. Anderson, David P. Figgitt and R.K. Ralph and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Cancer Research.

In The Last Decade

Swarna A. Gamage

38 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Swarna A. Gamage New Zealand 20 912 830 184 151 141 39 1.7k
V. L. Narayanan United States 24 1.0k 1.1× 890 1.1× 106 0.6× 152 1.0× 143 1.0× 68 2.2k
Vincent Lisowski France 21 1.4k 1.5× 907 1.1× 40 0.2× 77 0.5× 143 1.0× 58 2.3k
Marco Radi Italy 29 981 1.1× 1.4k 1.7× 50 0.3× 70 0.5× 121 0.9× 97 2.5k
Mark Searcey United Kingdom 27 1.2k 1.4× 837 1.0× 121 0.7× 90 0.6× 194 1.4× 84 1.9k
Paola B. Arimondo France 33 3.0k 3.3× 438 0.5× 102 0.6× 215 1.4× 101 0.7× 115 3.6k
Shelli R. McAlpine Australia 28 1.6k 1.8× 586 0.7× 36 0.2× 100 0.7× 261 1.9× 87 2.2k
Gerrit‐Jan Koomen Netherlands 22 1.0k 1.1× 818 1.0× 63 0.3× 123 0.8× 132 0.9× 75 2.2k
Marie‐Hélène David‐Cordonnier France 33 1.7k 1.8× 912 1.1× 168 0.9× 493 3.3× 149 1.1× 69 2.5k
Hsueh‐Yun Lee Taiwan 21 824 0.9× 821 1.0× 60 0.3× 82 0.5× 139 1.0× 56 1.6k
Amir Nasrolahi Shirazi United States 25 1.1k 1.2× 762 0.9× 51 0.3× 62 0.4× 111 0.8× 64 1.9k

Countries citing papers authored by Swarna A. Gamage

Since Specialization
Citations

This map shows the geographic impact of Swarna A. Gamage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swarna A. Gamage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swarna A. Gamage more than expected).

Fields of papers citing papers by Swarna A. Gamage

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Swarna A. Gamage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swarna A. Gamage. The network helps show where Swarna A. Gamage may publish in the future.

Co-authorship network of co-authors of Swarna A. Gamage

This figure shows the co-authorship network connecting the top 25 collaborators of Swarna A. Gamage. A scholar is included among the top collaborators of Swarna A. Gamage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Swarna A. Gamage. Swarna A. Gamage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghosh, Arun K., et al.. (2024). Design, synthesis, and X-ray structural studies of a series of highly potent, selective, and drug-like G protein-coupled receptor kinase 5 inhibitors. European Journal of Medicinal Chemistry. 282. 117024–117024. 3 indexed citations
2.
Gamage, Swarna A., Jackie D. Kendall, Woo Jung Lee, et al.. (2019). Synthesis and biological evaluation of solubilized sulfonamide analogues of the phosphatidylinositol 3-kinase inhibitor ZSTK474. Bioorganic & Medicinal Chemistry. 27(8). 1529–1545. 13 indexed citations
3.
Gamage, Swarna A., Julie A. Spicer, Kit Yee Tsang, et al.. (2019). Synthesis and Evaluation of Imidazo[1,2‐a]pyridine Analogues of the ZSTK474 Class of Phosphatidylinositol 3‐Kinase Inhibitors. Chemistry - An Asian Journal. 14(8). 1249–1261. 8 indexed citations
4.
Denny, William A., et al.. (2017). Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides. Journal of Controlled Release. 250. 62–76. 222 indexed citations
5.
Gamage, Swarna A., Kit Yee Tsang, Jack U. Flanagan, et al.. (2017). Synthesis and biological evaluation of sulfonamide analogues of the phosphatidylinositol 3-kinase inhibitor ZSTK474. Bioorganic & Medicinal Chemistry. 25(20). 5859–5874. 19 indexed citations
6.
Harvey, Martyn, Jamie Sleigh, Logan J. Voss, et al.. (2015). Development of Rapidly Metabolized and Ultra-Short-Acting Ketamine Analogs. Anesthesia & Analgesia. 121(4). 925–933. 17 indexed citations
7.
Evans, Genevieve L., Swarna A. Gamage, Esther M. M. Bulloch, et al.. (2014). Repurposing the Chemical Scaffold of the Anti‐Arthritic Drug Lobenzarit to Target Tryptophan Biosynthesis in Mycobacterium tuberculosis. ChemBioChem. 15(6). 852–864. 17 indexed citations
8.
Gamage, Swarna A., Darby G. Brooke, Sanjeev Redkar, et al.. (2013). Structure–activity relationships for 4-anilinoquinoline derivatives as inhibitors of the DNA methyltransferase enzyme DNMT1. Bioorganic & Medicinal Chemistry. 21(11). 3147–3153. 11 indexed citations
9.
Jose, Jiney, Swarna A. Gamage, Martyn Harvey, et al.. (2013). Structure–activity relationships for ketamine esters as short-acting anaesthetics. Bioorganic & Medicinal Chemistry. 21(17). 5098–5106. 19 indexed citations
10.
Rewcastle, Gordon W., Swarna A. Gamage, Jack U. Flanagan, et al.. (2013). Synthesis and biological evaluation of novel phosphatidylinositol 3-kinase inhibitors: Solubilized 4-substituted benzimidazole analogs of 2-(difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazole (ZSTK474). European Journal of Medicinal Chemistry. 64. 137–147. 18 indexed citations
11.
Bera, Asim K., et al.. (2010). Structure of theD-alanylgriseoluteic acid biosynthetic protein EhpF, an atypical member of the ANL superfamily of adenylating enzymes. Acta Crystallographica Section D Biological Crystallography. 66(6). 664–672. 15 indexed citations
12.
Gamage, Swarna A., Gordon W. Rewcastle, Bruce C. Baguley, Peter Charlton, & William A. Denny. (2005). Phenazine-1-carboxamides: Structure–cytotoxicity relationships for 9-substituents and changes in the H-bonding pattern of the cationic side chain. Bioorganic & Medicinal Chemistry. 14(4). 1160–1168. 15 indexed citations
13.
Anderson, Robert F., S.S. Shinde, Michael P. Hay, Swarna A. Gamage, & William A. Denny. (2005). Radical properties governing the hypoxia-selective cytotoxicity of antitumor 3-amino-1,2,4-benzotriazine 1,4-dioxides. Organic & Biomolecular Chemistry. 3(11). 2167–2167. 27 indexed citations
14.
Gamage, Swarna A., Julie A. Spicer, Gordon W. Rewcastle, et al.. (2002). Structure−Activity Relationships for Pyrido-, Imidazo-, Pyrazolo-, Pyrazino-, and Pyrrolophenazinecarboxamides as Topoisomerase-Targeted Anticancer Agents. Journal of Medicinal Chemistry. 45(3). 740–743. 126 indexed citations
15.
Spicer, Julie A., Swarna A. Gamage, Graeme J. Finlay, & William A. Denny. (2002). Synthesis and evaluation of unsymmetrical bis(arylcarboxamides) designed as topoisomerase-Targeted anticancer drugs. Bioorganic & Medicinal Chemistry. 10(1). 19–29. 20 indexed citations
16.
Gamage, Swarna A., Julie A. Spicer, Graham J. Atwell, et al.. (1999). Structure−Activity Relationships for Substituted Bis(acridine-4-carboxamides):  A New Class of Anticancer Agents. Journal of Medicinal Chemistry. 42(13). 2383–2393. 132 indexed citations
17.
Spicer, Julie A., Swarna A. Gamage, Graham J. Atwell, et al.. (1997). Structure−Activity Relationships for Acridine-Substituted Analogues of the Mixed Topoisomerase I/II InhibitorN-[2-(Dimethylamino)ethyl]acridine-4-carboxamide. Journal of Medicinal Chemistry. 40(12). 1919–1929. 64 indexed citations
18.
Figgitt, David P., William A. Denny, Swarna A. Gamage, & R.K. Ralph. (1994). Structure-activity relationships of 9-anilinoacridines as inhibitors of human DNA topoisomerase II.. PubMed. 9(3). 199–208. 5 indexed citations
19.
Gamage, Swarna A., Prapon Wilairat, S.J. Wojcik, et al.. (1994). Synthesis and in vitro Evaluation of 9-Anilino-3,6-diaminoacridines Active Against a Multidrug-Resistant Strain of the Malaria Parasite Plasmodium falciparum. Journal of Medicinal Chemistry. 37(10). 1486–1494. 85 indexed citations
20.
Wilairat, Prapon, et al.. (1993). Structure-activity relationships and modes of action of 9-anilinoacridines against chloroquine-resistant Plasmodium falciparum in vitro. Antimicrobial Agents and Chemotherapy. 37(3). 403–406. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026